Your browser doesn't support javascript.
loading
Association of Lymph Nodes Positive Rate With the Risk of Recurrence in Patients With Stage T1 Papillary Thyroid Cancer.
Qin, Chao; Cai, Sijia; Yin, Min; Ma, Ben; Shen, Cenkai; Zhang, Yanzhi; Ji, Qinghai; Liao, Tian; Wang, Yu.
Afiliación
  • Qin C; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200000, China.
  • Cai S; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200000, China.
  • Yin M; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200000, China.
  • Ma B; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200000, China.
  • Shen C; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200000, China.
  • Zhang Y; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200000, China.
  • Ji Q; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200000, China.
  • Liao T; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200000, China.
  • Wang Y; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai 200000, China.
J Endocr Soc ; 8(8): bvae131, 2024 Jul 01.
Article en En | MEDLINE | ID: mdl-39015141
ABSTRACT
The incidence of lymph node metastasis in papillary thyroid carcinoma (PTC) is common and a significant risk factor for local recurrence; however, its impact on recurrence patterns among low-risk patients remains uncertain. We aimed to elucidate the effect of metastatic lymph node on recurrence type. The medical records of 1209 patients with stage T1 PTC who underwent unilateral thyroidectomy with ipsilateral central lymph node dissection were retrospectively analyzed. The study first identified risk factors for different types of recurrence and then categorized patients as high or low risk based on their lymph node positive ratio (LNPR). The diagnostic accuracy of LNPR in predicting recurrence was compared using receiver operating characteristic (ROC) curve analysis, while differences in recurrence-free survival were assessed using the Kaplan-Meier method. During follow-up, a total of 502 (41.5%) patients had central lymph node metastasis and 52 (4.3%) patients experienced recurrence. Notably, LNPR was significantly higher in relapsed patients compared to nonrelapsed patients, with mean values of 0.45 and 0.23, respectively (P < .001). The recurrence rate of residual thyroid did not differ significantly across different T stages (P = .679), N stages (P = .415), or LNPR risk groups (P = .175). However, the recurrence rate of lymph nodes showed a significant correlation with LNPR (P < .001). The area under the ROC curves for LNPR risk stratification at 5 and 10 years were approximately 0.691 and 0.634, respectively, both of which outperformed N stage. The findings underscore the significance of LNPR's reliability as a prognostic indicator for local lymph node recurrence in patients diagnosed with T1 stage PTC.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Endocr Soc Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: J Endocr Soc Año: 2024 Tipo del documento: Article